Serum zinc is decreased in Alzheimer’s disease and serum arsenic correlates positively with cognitive ability
暂无分享,去创建一个
V. Mok | E. Hui | J. Woo | A. Bush | C. Lam | W. Goggins | L. Baum | B. Zee | T. Kwok | V. Leung | L. Lam | H. Chiu | I. Chan | V. Lui | J. Tsoh | S. K. Cheung | Chelsia Ng | William K F Cheng | M. Chan | S. Szeto | William K. F. Cheng
[1] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[2] P. Pasqualetti,et al. Longitudinal prognostic value of serum “free” copper in patients with Alzheimer disease , 2009, Neurology.
[3] Shih-Yi Huang,et al. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[4] E. Londos,et al. Metal Concentrations in Plasma and Cerebrospinal Fluid in Patients with Alzheimer’s Disease , 2008, Dementia and Geriatric Cognitive Disorders.
[5] J. D. Robertson,et al. Serum zinc in the progression of Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.
[6] S. Gharibzadeh,et al. Arsenic exposure may be a risk factor for Alzheimer's disease. , 2008, The Journal of neuropsychiatry and clinical neurosciences.
[7] J. Escanero,et al. Serum aluminum levels in alzheimer’s disease and other senile dementias , 2007, Biological Trace Element Research.
[8] V. Haroutunian,et al. Elevated cortical zinc in Alzheimer disease , 2006, Neurology.
[9] P. Pasqualetti,et al. Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β-amyloid, and h-tau , 2006, Neurology.
[10] Li-Tung Huang,et al. Menhaden fish oil improves spatial memory in rat pups following recurrent pentylenetetrazole-induced seizures , 2006, Epilepsy & Behavior.
[11] A. Blackburn,et al. Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases , 2005, Pharmacogenetics and genomics.
[12] S. Sensi,et al. Zinc dyshomeostasis: a key modulator of neuronal injury. , 2005, Journal of Alzheimer's disease : JAD.
[13] R. Palmiter,et al. Neuronal Zinc Exchange with the Blood Vessel Wall Promotes Cerebral Amyloid Angiopathy in an Animal Model of Alzheimer's Disease , 2004, The Journal of Neuroscience.
[14] A. Passaro,et al. Trace elements and cognitive impairment: an elderly cohort study. , 2004, Archives of gerontology and geriatrics. Supplement.
[15] M. Miclea,et al. A behavioral and ultrastructural dissection of the interference of aluminum with aging. , 2004, Journal of Alzheimer's disease : JAD.
[16] Eden R Martin,et al. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. , 2003, Human molecular genetics.
[17] A. Mackinnon,et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. , 2003, Archives of neurology.
[18] D. Bennett,et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. , 2003, Archives of neurology.
[19] N. Delibaş,et al. Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study. , 2002, Croatian medical journal.
[20] M. Orrell,et al. Vitamins, Trace Elements, and Antioxidant Status in Dementia Disorders , 2001, International Psychogeriatrics.
[21] P. Bolger,et al. Dietary arsenic intakes in the United States: FDA Total Diet Study, September 1991-December 1996. , 1999, Food additives and contaminants.
[22] Arroyo,et al. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers* , 1999, European journal of clinical investigation.
[23] W. D. Ehmann,et al. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. , 1998, Neurotoxicology.
[24] N. Roberts,et al. Increased absorption of aluminium from a normal dietary intake in dementia. , 1998, Journal of inorganic biochemistry.
[25] G. Perry,et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[26] W. D. Ehmann,et al. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress , 1996, Journal of the Neurological Sciences.
[27] E. Bjertness,et al. Content of Brain Aluminum Is Not Elevated in Alzheimer Disease , 1996, Alzheimer disease and associated disorders.
[28] W. Markesbery,et al. Serum zinc, senile plaques, and neurofibrillary tangles: findings from the Nun Study. , 1995, Neuroreport.
[29] H. Chiu,et al. Reliability and Validity of the Cantonese Version of Mini-Mental State Examination-A Preliminary Study , 1994 .
[30] I. Ferrier,et al. Gastrointestinal absorption of aluminium in Alzheimer's disease: response to aluminium citrate. , 1992, Age and ageing.